Steven Altschuler - 14 Jun 2023 Form 4 Insider Report for Orchard Therapeutics plc

Role
Director
Signature
/s/ Frank Thomas, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 16:30:21 UTC
Previous filing
05 Apr 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +105,000 $0.000000 105,000 14 Jun 2023 Ordinary Shares 105,000 $0.4950 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares.